NOT_YET_RECRUITING
Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research
Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Conditions:
🦠 Anxiety Disorder
🗓️ Study Start (Actual) December 2024
🗓️ Primary Completion (Estimated) December 2025
✅ Study Completion (Estimated) December 2026
👥 Enrollment (Estimated) 500
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 San Francisco, California, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Aged ≥ 18 years old
    • * Diagnosis of anxiety disorder
    • * Able to comprehend the investigational nature of the protocol and provide informed consent

    Exclusion Criteria:

    • * Female patients who are currently pregnant or nursing
    • * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
    • * Inability to perform regular electronic reporting
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 24 November 2023
  • First Submitted that Met QC Criteria 24 November 2023
  • First Posted 4 December 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 24 November 2023
  • Last Update Posted 4 December 2023
  • Last Verified November 2023